Skip to product information
1 of 1

David Gordon

The American Cardiovascular Pandemic: A 100-Year History

The American Cardiovascular Pandemic: A 100-Year History

Dispatches within 7 to 10 working days
Regular price £36.75 GBP
Regular price £39.95 GBP Sale price £36.75 GBP
8% OFF Sold out
Tax included. Shipping calculated at checkout.

YOU SAVE £3.20

  • Condition: Brand new
  • UK Delivery times: Usually arrives within 2 - 3 working days
  • UK Shipping: Fee starts at £2.39. Subject to product weight & dimension
Trustpilot 4.5 stars rating  Excellent
We're rated excellent on Trustpilot.
  • More about The American Cardiovascular Pandemic: A 100-Year History

During the first half of the 20th century, heart attacks and strokes became the leading cause of death, killing millions. However, significant progress has been made in the past 50 years, with death rates from heart attacks and strokes falling by 80% due to research, epidemiology, and public health efforts.

Format: Paperback / softback
Length: 277 pages
Publication date: 30 May 2022
Publisher: McFarland & Co Inc


As the 20th century progressed, a remarkable shift occurred in the global landscape of health. The lives of Americans and citizens of other industrializing nations experienced a remarkable surge in affluence and ease, leading to a significant decline in infectious diseases as the primary cause of death. This transformative shift, which took place during the first half of the century, resulted in the tragic loss of millions of lives in both the United States and across the globe.

While cardiovascular disease remains a formidable and widespread health concern, the remarkable decline in per capita deaths is one of the greatest achievements in modern public health and medicine. Over the past half-century, death rates from heart attacks and strokes have plummeted by an astonishing 80 percent. This remarkable progress has been the result of a tireless effort by a multitude of individuals and organizations.

Basic and applied laboratory research has played a pivotal role in understanding the underlying mechanisms of cardiovascular disease and developing innovative treatments. Physicians, scientists, and public health experts have conducted extensive epidemiological studies that have shed light on the risk factors, prevention strategies, and treatment options for cardiovascular diseases.

The understanding of the role of lifestyle factors, such as diet, exercise, and smoking, in the development and progression of cardiovascular disease has been a major breakthrough. Public health campaigns, education programs, and policy initiatives have focused on promoting healthy behaviors and reducing the prevalence of risk factors, leading to a significant reduction in cardiovascular mortality.

In addition to these scientific advancements, technological innovations have also played a significant role in the treatment and management of cardiovascular diseases. The development of new diagnostic tools, such as CT scans, MRI, and echocardiography, has enabled physicians to accurately diagnose and monitor cardiovascular conditions, leading to timely intervention and improved outcomes.

Furthermore, the advent of cardiovascular medications, such as statins, beta-blockers, and angiotensin-converting enzyme (ACE) inhibitors, has revolutionized the treatment of cardiovascular diseases. These medications have been shown to reduce blood pressure, lower cholesterol levels, and improve heart function, thereby reducing the risk of heart attacks and strokes.

Despite these remarkable achievements, cardiovascular disease remains a significant public health challenge. The prevalence of cardiovascular diseases continues to rise in developing countries, particularly in low- and middle-income nations. Inequalities in access to healthcare, lack of education and awareness about cardiovascular diseases, and the impact of lifestyle factors such as poverty and urbanization contribute to the ongoing burden of cardiovascular disease.

To address these challenges, ongoing research and innovation are crucial. Governments, healthcare organizations, and individuals must work together to promote cardiovascular health, reduce the risk of cardiovascular diseases, and provide access to quality healthcare for all. This includes initiatives to improve education and awareness about cardiovascular diseases, promote healthy lifestyles, invest in healthcare infrastructure, and develop targeted interventions for high-risk populations.

In conclusion, the decline in cardiovascular mortality since 1900 is a testament to the power of science, innovation, and public health efforts. While cardiovascular disease remains a serious health concern, the significant progress made in the past half-century has provided hope for a healthier future. By continuing to invest in research, innovation, and public health initiatives, we can build upon this progress and ensure that cardiovascular diseases are no longer a leading cause of death worldwide.

Weight: 349g
Dimension: 229 x 152 (mm)
ISBN-13: 9781476685120

UK and International shipping information

UK Delivery and returns information:

  • Delivery within 2 - 3 days when ordering in the UK.
  • Shipping fee for UK customers from £2.39. Fully tracked shipping service available.
  • Returns policy: Return within 30 days of receipt for full refund.

International deliveries:

Shulph Ink now ships to Australia, Belgium, Canada, France, Germany, Ireland, Italy, India, Luxembourg Saudi Arabia, Singapore, Spain, Netherlands, New Zealand, United Arab Emirates, United States of America.

  • Delivery times: within 5 - 10 days for international orders.
  • Shipping fee: charges vary for overseas orders. Only tracked services are available for most international orders. Some countries have untracked shipping options.
  • Customs charges: If ordering to addresses outside the United Kingdom, you may or may not incur additional customs and duties fees during local delivery.
View full details